Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentalpha DNA polymerase:primase complex

POLA1 PRIM2

1.13e-045712GO:0005658
DomainARM-type_fold

DOCK2 DOCK11 MROH2A CLTC LTA4H BTAF1 ARMCX5 TARBP1

4.73e-05339728IPR016024
DomainDOCK_C

DOCK2 DOCK11

7.88e-0411722IPR010703
DomainDHR-1_domain

DOCK2 DOCK11

7.88e-0411722IPR027007
DomainDHR_2

DOCK2 DOCK11

7.88e-0411722PS51651
DomainDHR_1

DOCK2 DOCK11

7.88e-0411722PS51650
DomainDOCK-C2

DOCK2 DOCK11

7.88e-0411722PF14429
DomainDHR-2

DOCK2 DOCK11

7.88e-0411722IPR027357
DomainDHR-2

DOCK2 DOCK11

7.88e-0411722PF06920
DomainDOCK

DOCK2 DOCK11

7.88e-0411722IPR026791
DomainARM-like

DOCK2 MROH2A BTAF1 ARMCX5 TARBP1

3.87e-03270725IPR011989
DomainNA-bd_OB-fold

DIS3L SRBD1 PYHIN1

4.05e-0383723IPR012340
DomainSNF2_N

RAD54B BTAF1

6.75e-0332722IPR000330
Domain-

ATP8B4 ATP7A

6.75e-03327223.40.1110.10
DomainSNF2_N

RAD54B BTAF1

6.75e-0332722PF00176
Domain-

ATP8B4 ATP7A

6.75e-03327222.70.150.10
DomainDeath

ANK3 DTHD1

7.16e-0333722PF00531
PathwayREACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION

ORC2 POLA1 PRIM2

7.35e-0522533M6768
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

SIN3B PARP4 TBC1D30 DOCK11 POLA1 CLTC LTA4H USP39 ZZEF1 HSPA5 OMG

4.41e-07736741129676528
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

POLA1 RPS7 CLTC MACF1 HELZ LTA4H NUP214 NKRF RBM34 TASOR2

1.24e-06653741022586326
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

RBBP6 RPS7 CLTC HELZ LTV1 LARP1B SRBD1 HSPA5 NKRF RBM34

1.74e-06678741030209976
Pubmed

The C-terminal domain of the DNA polymerase catalytic subunit regulates the primase and polymerase activities of the human DNA polymerase α-primase complex.

POLA1 PRIM2

4.47e-06274224962573
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

ORC2 SIN3B POLA1 RAD54B BTAF1 USP39 MORC3 SRBD1 RBM34

5.78e-0660874936089195
Pubmed

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.

DOCK2 UAP1 ANK3 RPS7 CLTC MACF1 LTA4H ZZEF1 HSPA5 MYO16

8.05e-06807741030575818
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DOCK2 SIN3B PARP4 ATP8B4 TBC1D30 DIS3L MACF1 MORC3

1.02e-0549374815368895
Pubmed

Novel oxygen sensing mechanism in the spinal cord involved in cardiorespiratory responses to hypoxia.

TRPA1 NOS1

1.34e-05374235333571
Pubmed

The role of brain-derived neurotrophic factor (BDNF)-induced XBP1 splicing during brain development.

HSPA5 BDNF

1.34e-05374217890727
Pubmed

nNOS-induced tyrosine nitration of TRKB impairs BDNF signaling and restrains neuronal plasticity.

NOS1 BDNF

1.34e-05374236682419
Pubmed

Physical mapping of the genes for three components of the mouse DNA replication complex: polymerase alpha to the X chromosome, primase p49 subunit to chromosome 10, and primase p58 subunit to chromosome 1.

POLA1 PRIM2

1.34e-0537422037291
Pubmed

RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.

SIN3B ANK3 RPS7 MACF1 HELZ HSPA5

2.13e-0526374634702444
Pubmed

DNA replication in vitro by recombinant DNA-polymerase-alpha-primase.

POLA1 PRIM2

2.67e-0547428026492
Pubmed

Mechanism of Concerted RNA-DNA Primer Synthesis by the Human Primosome.

POLA1 PRIM2

2.67e-05474226975377
Pubmed

Molecular cloning of the cDNAs for the four subunits of mouse DNA polymerase alpha-primase complex and their gene expression during cell proliferation and the cell cycle.

POLA1 PRIM2

2.67e-0547428463324
Pubmed

Molecular architecture of the mouse DNA polymerase alpha-primase complex.

POLA1 PRIM2

2.67e-05474210523676
Pubmed

A conserved motif in the C-terminal tail of DNA polymerase α tethers primase to the eukaryotic replisome.

POLA1 PRIM2

2.67e-05474222593576
Pubmed

Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with DNA polymerase α-primase.

POLA1 PRIM2

2.67e-05474234719824
Pubmed

N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.

ORC2 SIN3B RBBP6 MACF1 HELZ LTA4H LTV1 BTAF1 NUP214 NKRF

2.82e-05934741033916271
Pubmed

A CRISPR-based screen for Hedgehog signaling provides insights into ciliary function and ciliopathies.

POLA1 PRIM2 CLTC NUP214 PZP HSPA5

3.27e-0528474629459677
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

DOCK2 ORC2 PARP4 MACF1 BTAF1 USP39 HSPA5 GULP1

3.35e-0558274820467437
Pubmed

Control of complex formation of DNA polymerase alpha-primase and cell-free DNA replication by the C-terminal amino acids of the largest subunit p180.

POLA1 PRIM2

4.45e-05574212220650
Pubmed

STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production.

USP39 SRBD1 DTHD1 HSPA5 NKRF RBM34

5.92e-0531674631665637
Pubmed

The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.

POLA1 PRIM2 RPS7 CLTC NUP214 USP39 HSPA5 NKRF

6.38e-0563874833239621
Pubmed

DNA primase from KB cells. Characterization of a primase activity tightly associated with immunoaffinity-purified DNA polymerase-alpha.

POLA1 PRIM2

6.66e-0567426693436
Pubmed

Warm-Sensitive Neurons that Control Body Temperature.

NOS1 BDNF

6.66e-05674227616062
Pubmed

A human MAP kinase interactome.

ANK3 RBBP6 CLTC MACF1 HELZ NUP214 HSPA5

8.00e-0548674720936779
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

UAP1 C2CD3 DOCK11 RPS7 MACF1 PLEKHA2 HELZ MORC3 LARP1B

8.79e-0586174936931259
Pubmed

Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.

ORC2 RBBP6 POLA1 BTAF1 SRBD1 NKRF

8.99e-0534174632971831
Pubmed

Mapping specific protein-protein interactions within the core component of the breast cell DNA synthesome.

POLA1 PRIM2

9.31e-0577429563011
Pubmed

Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments.

POLA1 PRIM2

9.31e-05774228757209
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

VWA8 RBBP6 APOOL RPS7 CLTC MACF1 USP39 PZP HSPA5 NKRF

9.63e-051082741038697112
Pubmed

BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.

ORC2 RBBP6 RPS7 CLTC HELZ LTV1 NUP214 MORC3 HSPA5 NKRF RBM34

1.04e-041318741130463901
Pubmed

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.

RPS7 HELZ SRBD1 HSPA5 NKRF

1.16e-0422374520020773
Pubmed

AnkG hemizygous mice present cognitive impairment and elevated anxiety/depressive-like traits associated with decreased expression of GABA receptors and postsynaptic density protein.

ANK3 BDNF

1.24e-04874228821923
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

INTU VWA8 KMT5B DIS3L RBBP6 FAT3 MACF1 HELZ ZZEF1 NKRF

1.24e-041116741031753913
Pubmed

Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.

POLA1 PRIM2 RPS7 CLTC MACF1 LTV1 NUP214 SRBD1 HSPA5 NKRF RBM34

1.31e-041353741129467282
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

RBBP6 RPS7 LTV1 USP39 LARP1B SRBD1 NKRF RBM34

1.37e-0471374829802200
Pubmed

USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

FAT3 CLTC MACF1 LTV1 NKRF

1.46e-0423474536243803
Pubmed

The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.

PARP4 PLEKHA2 LTV1 GULP1

1.51e-0412574429467281
Pubmed

Matrix-screening reveals a vast potential for direct protein-protein interactions among RNA binding proteins.

DIS3L RBBP6 RPS7 USP39 LARP1B SRBD1 HSPA5 NKRF

1.51e-0472374834133714
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

PARP4 NF2 DOCK11 DIS3L POLA1 MACF1 HELZ LARP1B

1.53e-0472474836232890
Pubmed

Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain.

NOS1 BDNF

1.59e-04974212798291
Pubmed

SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.

SIN3B ANK3 NF2 RBBP6 CLTC HSPA5 NKRF

1.70e-0454974738280479
Pubmed

Study of FOXO1-interacting proteins using TurboID-based proximity labeling technology.

XIRP2 RBBP6 RPS7 HSPA5 TASOR2

1.74e-0424374536964488
Pubmed

Plasticity in the Glucagon Interactome Reveals Novel Proteins That Regulate Glucagon Secretion in α-TC1-6 Cells.

ATP7A RPS7 CLTC PZP HSPA5

1.87e-0424774530713523
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

RBBP6 HELZ NUP214 USP39 HSPA5

1.98e-0425074533536335
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

PARP4 RPS7 LTV1 BTAF1 USP39 LARP1B HSPA5 NKRF RBM34

2.16e-0497174933306668
Pubmed

Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin.

ANK3 NOS1

2.43e-041174210995443
Pubmed

Transcriptome Analysis of Cardiac Hypertrophic Growth in MYBPC3-Null Mice Suggests Early Responders in Hypertrophic Remodeling.

XIRP2 MYBPC2

2.43e-041174230410445
Pubmed

Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens.

DOCK11 MACF1 PLEKHA2 LTA4H

2.52e-0414374430397336
Pubmed

The splicing regulators Esrp1 and Esrp2 direct an epithelial splicing program essential for mammalian development.

UAP1 NF2 MACF1

2.76e-045974326371508
Pubmed

Evidence for the involvement of neurotrophins in muscle transdifferentiation and acetylcholine receptor transformation in the esophagus of Myf5(-/-):MyoD(-/-) and NT-3(-/-) embryos.

NOS1 BDNF

2.91e-041274215497153
Pubmed

The unfolded protein response contributes to preimplantation mouse embryo death in the DDK syndrome.

USP39 HSPA5

2.91e-041274219129515
Pubmed

MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity.

RBBP6 POLA1 PRIM2 USP39

3.03e-0415074422678362
Pubmed

Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.

ANK3 XIRP2 RBBP6 CLTC NUP214 TASOR2

3.14e-0443074635044719
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

RBBP6 RPS7 CLTC MACF1 HELZ LARP1B NKRF RBM34

3.17e-0480774822681889
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

RBBP6 RPS7 CLTC LTV1 USP39 SRBD1 HSPA5 NKRF RBM34 TASOR2

3.23e-041257741036526897
Pubmed

WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.

NF2 RPS7 CLTC SRBD1 HSPA5 NKRF RBM34

3.38e-0461574731048545
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

C2CD3 ANK3 NF2 PRIM2 RPS7 CLTC HELZ PPM1K HSPA5

3.81e-04104974927880917
Pubmed

MANF Ablation Causes Prolonged Activation of the UPR without Neurodegeneration in the Mouse Midbrain Dopamine System.

HSPA5 BDNF

4.00e-041474232005751
Pubmed

Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons.

NOS1 BDNF

4.00e-041474212810600
Pubmed

Identification of an evolutionarily conserved superfamily of DOCK180-related proteins with guanine nucleotide exchange activity.

DOCK2 DOCK11

4.00e-041474212432077
Pubmed

ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia.

LTA4H ARMCX5 HSPA5 RBM34

4.44e-0416674435687106
Pubmed

Ku antigen, an origin-specific binding protein that associates with replication proteins, is required for mammalian DNA replication.

ORC2 POLA1

4.61e-041574212393188
Pubmed

Molecular phylogenetics and the origins of placental mammals.

ATP7A BDNF

4.61e-041574211214319
Pubmed

Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.

PARP4 RAD54B HELZ BTAF1 PZP ZZEF1 NKRF

4.70e-0465074738777146
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

RBBP6 HELZ NUP214 CARNMT1 HSPA5 NKRF RBM34

4.92e-0465574735819319
Pubmed

Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.

ORC2 RBBP6 NUP214 MORC3 NKRF TASOR2

4.97e-0446974627634302
Pubmed

Clathrin facilitates the morphogenesis of retrovirus particles.

CLTC HSPA5

5.26e-041674221738476
Pubmed

Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics.

SIN3B NF2 DOCK11 NUP214 USP39 PZP

5.32e-0447574631040226
Pubmed

Characterization of hNek6 interactome reveals an important role for its short N-terminal domain and colocalization with proteins at the centrosome.

RBBP6 RPS7

5.95e-041774220873783
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

PARP4 RPS7 CLTC NUP214 HSPA5 NKRF

6.53e-0449474626831064
Pubmed

Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.

NF2 RBBP6 MROH2A MACF1 RBM34 TASOR2

6.67e-0449674631343991
Pubmed

Genome-wide meta-analysis identifies six novel loci associated with habitual coffee consumption.

PPM1K BDNF

6.68e-041874225288136
Pubmed

Deficiency of TRPM2 leads to embryonic neurogenesis defects in hyperthermia.

TRPA1 BDNF

6.68e-041874231911949
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

PARP4 NF2 XIRP2 CLTC MACF1 MYBPC2

6.74e-0449774623414517
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ANK3 XIRP2 DOCK11 NUP214 USP39 RBM34

6.74e-0449774636774506
Pubmed

Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.

POLA1 CLTC NUP214 MORC3 HSPA5

7.23e-0433274532786267
Pubmed

Nuclear actin interactome analysis links actin to KAT14 histone acetyl transferase and mRNA splicing.

ORC2 RBBP6 POLA1 PRIM2 RPS7 CLTC

7.39e-0450674630890647
Pubmed

Hrd1-mediated ACLY ubiquitination alleviate NAFLD in db/db mice.

CLTC HSPA5

7.46e-041974232888949
Pubmed

Identification of novel spartin-interactors shows spartin is a multifunctional protein.

CLTC HSPA5

7.46e-041974219765186
Pubmed

BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.

ATP7A ANK3 RPS7 MACF1 LTV1 NUP214 HSPA5

7.77e-0470874739231216
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

POLA1 RPS7 CLTC SRBD1 HSPA5

8.04e-0434074524332808
Pubmed

Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.

VWA8 POLA1 PRIM2 RPS7 CLTC MACF1 LTV1 USP39 HSPA5 TARBP1

8.10e-041415741028515276
Pubmed

Global Interactome Mapping of Mitochondrial Intermembrane Space Proteases Identifies a Novel Function for HTRA2.

ANK3 VWA8 APOOL BTAF1 NUP214 ZZEF1

8.10e-0451574631617661
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

RPS7 CLTC LTA4H USP39 LARP1B HSPA5 NKRF

8.16e-0471474728302793
Pubmed

Defining the membrane proteome of NK cells.

DOCK2 ORC2 PARP4 ATP7A NF2 RPS7 CLTC HELZ HSPA5

8.22e-04116874919946888
Pubmed

Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.

XIRP2 MACF1

8.28e-042074221689717
Pubmed

Genome-wide association study identifies variants associated with histologic features of nonalcoholic Fatty liver disease.

TEX36 PZP

9.14e-042174220708005
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

INTU C2CD3 RPS7 CLTC MACF1 SRBD1 DTHD1 HSPA5 TASOR2 MYBPC2

9.35e-041442741035575683
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

ORC2 RBBP6 RPS7 CLTC NUP214 HSPA5 NKRF TASOR2

9.49e-0495474836373674
Pubmed

OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.

NF2 HSPA5 NKRF

9.82e-049174330472188
Pubmed

TRIM65 regulates microRNA activity by ubiquitination of TNRC6.

ORC2 LTV1 ARMCX5 NKRF RBM34

1.09e-0336474524778252
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

CLTC SRBD1 HSPA5 NKRF RBM34 TASOR2

1.15e-0355174634728620
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

RBBP6 RPS7 MACF1 LTV1 SRBD1 NKRF RBM34

1.16e-0375974735915203
Pubmed

Direct interaction between the PRDM3 and PRDM16 tumor suppressors and the NuRD chromatin remodeling complex.

RPS7 CLTC LTV1 HSPA5

1.17e-0321574430462309
Pubmed

Transcription factor Foxp3 and its protein partners form a complex regulatory network.

ORC2 HELZ NUP214 NKRF RBM34

1.17e-0337074522922362
Pubmed

Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences.

ATP7A NF2

1.30e-03257428889551
Pubmed

E-cadherin interactome complexity and robustness resolved by quantitative proteomics.

ANK3 NF2 MACF1 PLEKHA2 NUP214 HSPA5

1.30e-0356574625468996
Cytoband1q42.3

TARBP1 RBM34

2.65e-04157421q42.3
CytobandXq21.1

ATP7A APOOL

1.31e-0333742Xq21.1
Cytoband3q25.1

AADAC ANKUB1

1.31e-03337423q25.1
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000

ORC2 POLA1 NRK PRIM2 RAD54B POLI HELZ LTV1 CARNMT1 MORC3 LARP1B NKRF TASOR2 MYBL1

6.72e-078227314gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000

ORC2 POLA1 PRIM2 RAD54B POLI HELZ LTV1 MORC3 LARP1B SRBD1 NKRF TASOR2 MYBL1

3.91e-068207313gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500

C2CD3 ANK3 NF2 FAT3 NUP214 GULP1

1.25e-05149736gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000

UAP1 C2CD3 ANK3 NF2 FAT3 NRK NUP214 GULP1

5.22e-05385738gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500

POLA1 RAD54B LTV1 LARP1B SRBD1 NKRF TASOR2 MYBL1

5.22e-05385738gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500

C2CD3 ANK3 NF2 FAT3 NRK NUP214 BDNF GULP1

7.70e-05407738gudmap_developingLowerUrinaryTract_e14.5_ urethra_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500

UAP1 C2CD3 ANK3 NF2 NUP214 GULP1

8.32e-05209736gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2
CoexpressionAtlasdev gonad_e11.5_F_PrimGermCell_Oct_top-relative-expression-ranked_1000

NF2 POLA1 NRK RAD54B POLI HELZ LTV1 CARNMT1 MORC3 NKRF MYBL1

8.46e-057997311gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000

C2CD3 ANK3 TBC1D30 NF2 RBBP6 FAT3 NRK NUP214 BDNF TASOR2 GULP1

9.14e-058067311DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000

C2CD3 ANK3 NF2 FAT3 NRK NUP214 GULP1

9.82e-05312737gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlaskidney_e15.5_SmlBldVes_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000

CSN3 FAT3 LTA4H LTV1 CARNMT1 KLHL32

1.44e-04231736gudmap_kidney_e15.5_SmlBldVes_Tie2_k3_1000
CoexpressionAtlasdev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000

ORC2 POLA1 PRIM2 RAD54B LTV1 MORC3 NKRF

2.41e-04361737gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k2_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000

C2CD3 ANK3 NF2 FAT3 NRK NUP214 GULP1

2.75e-04369737DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlasdev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#2_top-relative-expression-ranked_1000

ORC2 POLA1 RAD54B LTV1 MORC3 NKRF

3.08e-04266736gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k2_1000
CoexpressionAtlasDevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000

ATP8B4 ATP7A DOCK11 RPS7 CARNMT1 MORC3 LARP1B PPM1K TASOR2 MYBL1

3.11e-047767310gudmap_developingGonad_e14.5_ ovary_1000
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

VWA8 DIS3L RBBP6 POLA1 FAT3 BTAF1 BBS9 KLHL32 NKRF

3.95e-04654739Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

ATP7A DOCK11 NRK APOOL RPS7 CARNMT1 MORC3 PPM1K MYBL1 GULP1

4.11e-048047310gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasdev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500

POLA1 RAD54B POLI HELZ LTV1 NKRF MYBL1

4.88e-04406737gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500

ANK3 NF2 FAT3 NRK GULP1

5.49e-04194735DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500
CoexpressionAtlasDevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_top-relative-expression-ranked_1000

PARP4 C2CD3 NF2 VWA8 MROH2A APOOL BTAF1 NUP214 KLHL32 MYBL1

5.63e-048377310gudmap_developingKidney_e15.5_stage III -IV renal corpusc_1000
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500

UAP1 C2CD3 ANK3 TBC1D30 NF2 NUP214 GULP1

5.64e-04416737gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

UAP1 MACF1 PZP DTHD1 HSPA5 MYBL1 PYHIN1

3.76e-08196747c100967851f037b3522130a9e2a4175ad593ecbc
ToppCellLA-17._Lymphocyte|World / Chamber and Cluster_Paper

DOCK2 ATP8B4 PZP DTHD1 MYBL1 PYHIN1

5.22e-0717874634ec499d03cc198cfefa19a724d4c81974052f65
ToppCellLA-17._Lymphocyte|LA / Chamber and Cluster_Paper

DOCK2 ATP8B4 PZP DTHD1 MYBL1 PYHIN1

5.76e-071817463fd9f805fa46141b0fa7023ee5d8688d338635d5
ToppCellmild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANK3 PZP DTHD1 MYO16 MYBL1 PYHIN1

9.44e-07197746e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AADAC ANK3 TGDS LTA4H NPC2 HSPA5

9.73e-07198746aa80315395cb5dffc25927c8a77cd2037aea8772
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ANK3 MACF1 BTAF1 DTHD1 MYBL1 PYHIN1

1.00e-06199746f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 DOCK11 PZP DTHD1 MYBL1 PYHIN1

1.00e-06199746eb188b0b457136b6ee485d3b3052baa30d9c0002
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

ANK3 TGDS LTA4H NPC2 LARP1B HSPA5

1.03e-06200746e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae
ToppCellmild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MACF1 PZP DTHD1 HSPA5 MYBL1 PYHIN1

1.03e-06200746109f673a4967ffa52270a0b4f818b3461288db44
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 DOCK11 PZP DTHD1 MYBL1 PYHIN1

1.03e-06200746893bb7c25ad7c6589a4c7c0364c2ace666e9b4be
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 ATP8B4 ADGRE1 DTHD1 PYHIN1

6.64e-06158745ad1040bce6ad655c2502d9abb02507ecff177f83
ToppCellfacs-Lung-Endomucin_-18m-Myeloid-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 ATP8B4 ADGRE1 DTHD1 PYHIN1

6.64e-06158745ac7aef01eda1dca80d6c5b508649fcad55803a67
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TRPA1 PZP DTHD1 MYBL1 PYHIN1

7.06e-0616074579e833c904c762434993b5ec9d5e3540e695fad3
ToppCellPND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

AADAC ANK3 POLA1 CLTC NPC2

8.44e-06166745575c325db88d6909cdf0d5e664bd9098b89d4401
ToppCellfacs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PPP1R3A XIRP2 FAT3 RAD54B MYBPC2

8.69e-06167745d78356bf0c473816dbabaee51984940bd822f84e
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PPM1K ADGRE1 PZP DTHD1 MYBL1

9.47e-0617074528fb192b21cdc5a77ba4f276694cff852eb2304b
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-Natural_Killer_Cell_/_Natural_Killer_T_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PPM1K ADGRE1 PZP DTHD1 MYBL1

9.47e-06170745239cb4b801b2d71a6facb386f2684c0851504151
ToppCelldroplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

PRIM2 POLI LTV1 BTAF1 NUP214

1.00e-05172745ebeda7ef181cac0109be750a98e7589c615d2724
ToppCellLV-17._Lymphocyte|World / Chamber and Cluster_Paper

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.03e-05173745212f013ff761cbab24a537071739867c08c402a4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

TRPA1 TGDS PZP MYBL1 PYHIN1

1.12e-051767455914e7635474e7cf24d446bdb1423bc0807ee9c6
ToppCellLV|World / Chamber and Cluster_Paper

VWA8 XIRP2 USP39 PPM1K BDNF

1.25e-051807455ac6f485a58bb29462fec02dfbe8eb70864eafe3
ToppCellLV-17._Lymphocyte|LV / Chamber and Cluster_Paper

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.28e-0518174581fafa69c8c240250a667a5f3b321e8be1b9a288
ToppCellRA-17._Lymphocyte|RA / Chamber and Cluster_Paper

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.32e-05182745257a7847917b6ea1d60608183d90300bfd028758
ToppCellRA-17._Lymphocyte|World / Chamber and Cluster_Paper

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.35e-051837456397f684a50346fc42cccb5afbe10350f4b2d9b0
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XIRP2 MROH2A FAT3 NRK MYO16

1.39e-051847452cbed6462fea2622871bb7e49b0df3d984239281
ToppCell15-Distal-Immune-Hematopoietic,_B_Cells|Distal / Age, Tissue, Lineage and Cell class

DOCK2 ATP8B4 XIRP2 NOS1 PYHIN1

1.39e-05184745c294cd421f277992b56ae9c40b8f3948e33148fe
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XIRP2 MROH2A FAT3 NRK MYO16

1.39e-05184745ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

XIRP2 MROH2A FAT3 NRK MYO16

1.39e-051847452b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellControl-T_cells-CD8+_T_cells|Control / group, cell type (main and fine annotations)

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.43e-0518574502ab64c0166c0646d1d4c6ed110ef0b75a1096d0
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

ANK3 VWA8 XIRP2 PPM1K BDNF

1.43e-051857456baccb26f999145e51b91d94315bf8d4655bef31
ToppCellControl-T_cells-NK_cells|Control / group, cell type (main and fine annotations)

ATP8B4 PZP DTHD1 MYBL1 PYHIN1

1.43e-05185745755c0998c729f462399f1d5e88adf4bfae31be30
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.46e-051867459d576dce2c5deefef1adda16c6da7055c8d57f8f
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APOOL PPM1K PZP MYBL1 PYHIN1

1.50e-05187745cfdc1585c80d2bb475d9145395fb50a88c53f838
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APOOL PZP DTHD1 MYBL1 PYHIN1

1.50e-05187745b426a67b5669019115b58295ce7d304beeb75825
ToppCellfacs-Heart-LA/RA-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R3A ANK3 XIRP2 PZP KLHL32

1.58e-05189745a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCellfacs-Heart-LA/RA|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PPP1R3A ANK3 XIRP2 PZP KLHL32

1.58e-05189745efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.62e-05190745ba61f04fd38efae01f721ba616252d1372ff1002
ToppCellCOVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.62e-05190745e3ca3c9fb9e27670a5dd128dd6564ff98a57159e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK-T_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.62e-051907455a37568000dfc33fcbb59b578c1963fb7cf872ec
ToppCellCOVID-19-lung-CD8+_T_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.66e-05191745543f8ae07cc2e6950c888115a5ca9445e3c0f618
ToppCellCOVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations)

DOCK2 ANK3 DTHD1 MYBL1 PYHIN1

1.66e-051917457f64add931b64b8d35836fa6bee9ebab593844d3
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

ANK3 PZP DTHD1 MYBL1 PYHIN1

1.66e-051917454a29b7d5cd10e9077699d3aa76e3db6c4d5a0cf6
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.70e-05192745ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_T/NK|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.70e-05192745b498618505bb1b7ff9574d06875dd272c11bac39
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.70e-0519274558a7829b411b02b422ef75e2277a868969cc23e8
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

APOOL PZP DTHD1 MYBL1 PYHIN1

1.70e-0519274597c312c82ec025c13052f8d424b11c0034c8ea54
ToppCellCOVID-19-lung-CD8+_T_cells|lung / Disease (COVID-19 only), tissue and cell type

DOCK2 PZP DTHD1 MYBL1 PYHIN1

1.75e-05193745780e23e2705fc5c1b70e37568b79731ced5038bd
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.75e-05193745a594f89a18273797506287d9e22f72abe53e4920
ToppCellCOVID-19-kidney-T-cells-1|COVID-19 / Disease (COVID-19 only), tissue and cell type

DOCK2 DOCK11 DTHD1 MYBL1 PYHIN1

1.75e-051937455b84fa640cf30dea55fde53b810f850ff946d253
ToppCellChildren_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ATP8B4 PZP DTHD1 MYBL1 PYHIN1

1.75e-051937451cb666375bc4e1b11a146d20896c9b5ae6fd0887
ToppCellHealthy/Control-gd_T|Healthy/Control / Disease group and Cell class

PZP DTHD1 HSPA5 MYBL1 PYHIN1

1.88e-05196745a6f9e55cd1cd7facadb3f508bded68023c997f3f
ToppCellHealthy/Control-gd_T|World / Disease group and Cell class

PZP DTHD1 HSPA5 MYBL1 PYHIN1

1.88e-05196745b982c84552e7efbff2be861f0f569f40804f5d88
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANK3 TGDS LTA4H NPC2 HSPA5

1.93e-051977451485933986921ff45669d9b7501c8d17050b3e97
ToppCellCOVID-19-kidney-T-cells-1|kidney / Disease (COVID-19 only), tissue and cell type

DOCK2 DOCK11 DTHD1 MYBL1 PYHIN1

1.93e-051977459bb7faf4ef63cca4d06c60e6c05a9616fdb6b98e
ToppCellLPS_anti-TNF-Epithelial_alveolar-AT_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

ANK3 TGDS LTA4H NPC2 HSPA5

1.93e-051977451638959d7aecb9fc5285eb7e4a3103ca437989e2
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.98e-05198745a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
ToppCellhealthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass

MACF1 DTHD1 HSPA5 MYBL1 PYHIN1

1.98e-05198745d7053a898e04478c577381085f615edaad3cdc5b
ToppCellHealthy_donor-gd_T|Healthy_donor / disease group, cell group and cell class (v2)

PZP DTHD1 HSPA5 MYBL1 PYHIN1

1.98e-0519874525158815287efbdd8f463baa755cbb874f3905f3
ToppCellTracheal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DOCK11 PLEKHA2 PZP

1.98e-05198745cc5ca64749e2f4f1d373d9472824df85741702b7
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.98e-0519874576aff381403bc5a8a9cc73eb1e5dbdc0bac7de6c
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

INTU NRK MACF1 PZP MYO16

1.98e-051987450c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCellTracheal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DOCK11 PLEKHA2 PZP

1.98e-05198745d4d66f19df078bfc3a83d4664aaf9c7789bde1a5
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.98e-05198745a781fd35a7cda8b7760c2e3ddccaac7aac26c979
ToppCellLPS_IL1RA_TNF-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AADAC TGDS LTA4H NPC2 HSPA5

1.98e-05198745d499dced27b0c0e21acfda2c20fa5c114f605085
ToppCellhealthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass

MACF1 DTHD1 HSPA5 MYBL1 PYHIN1

1.98e-05198745aa33be29e26f1b8facfc894413099083ae3bbb1b
ToppCellHealthy_donor-gd_T|World / disease group, cell group and cell class (v2)

PZP DTHD1 HSPA5 MYBL1 PYHIN1

1.98e-051987450c3475936f148f2c026501c61b43bcb94d320c48
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.98e-05198745df399674345c45738d765a8354ea8d1484572c34
ToppCellCOVID-19_Mild-Lymphoid_T/NK-gd_T|COVID-19_Mild / Disease group, lineage and cell class

MACF1 PZP DTHD1 MYBL1 PYHIN1

1.98e-051987456aea5d00c417708f05b6d2dfe5a962d80864f8eb
ToppCellTracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 DOCK11 DTHD1 MYBL1 PYHIN1

2.02e-05199745598937913fe1f12d741fa49e23ae195a7be5cbe3
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.02e-0519974509e0b45529fa9d5fc86da1747b3fb3a238a09aa6
ToppCellTracheal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.02e-05199745713fab2e946b300d21215aff1553785e8857ce65
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.02e-0519974554b64f01e7a73a88bd92b6d4e73cccde60396b2d
ToppCellTracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.02e-05199745ffd5b4d58d81b76e01d87016209f16879d81c592
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.07e-052007457a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-T/NK-gd_T|COVID-19_Mild / Disease, condition lineage and cell class

MACF1 PZP DTHD1 MYBL1 PYHIN1

2.07e-052007456560753d3df2f87860b52052d4881aa45410f666
ToppCellmild-gd_T|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PZP DTHD1 HSPA5 MYBL1 PYHIN1

2.07e-052007452c21ede46a42b8e2f8e99ecca365baa52056eb17
ToppCellmild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

MACF1 PZP DTHD1 MYBL1 PYHIN1

2.07e-05200745d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 PLEKHA2 MYBL1 PYHIN1

2.07e-052007451db27223e307efca97502fca40ec5e4f8eea512b
ToppCellBronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.07e-052007457eed3d932018d6a87ce37d013883b371db55caeb
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.07e-052007457d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.07e-05200745d2422aaf807010194994db97142b9fd2e807312d
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.07e-052007456b34f2b85d4f83c1270ee151f602cba6f42042ba
ToppCellBronchial-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.07e-0520074556d738ff019682af7f1f8cbe7b262a75dc8596d5
ToppCellBronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.07e-052007450f8e2fed93cc103b20a825d8d3e83787c5c015cc
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.07e-0520074502c4169a23e5aaa0d4bfc78b51ba19ce8157dc3e
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.07e-05200745b2c5618aa1ac19423996336795dadb39ea57cda7
ToppCellTracheal-NucSeq-Immune_Lymphocytic-T|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 DOCK11 DTHD1 MYBL1 PYHIN1

2.07e-05200745dbbc7e16929e744b48017da068479a6046e99cf6
ToppCellBronchial-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 PZP DTHD1 MYBL1 PYHIN1

2.07e-05200745510d84bf7a4621b079e5a7330d25e04508c84a49
ToppCellParenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK2 ATP8B4 DTHD1 MYBL1 PYHIN1

2.07e-052007451d2ee63010b7b8b38bea7d3b30eebfbcdd18b967
ToppCellTCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-11|TCGA-Brain / Sample_Type by Project: Shred V9

DMRT3 TRPA1 ANKUB1 BBS9

2.74e-051047445114600bbadb5a0d31c164afd2e8c2a7865a1423
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9

TBC1D30 TARBP1 NKRF RBM34

8.25e-0513874493497c0a5d5e54006653b2dedc7a7041e1a613e6
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

DOCK11 ANKUB1 NRK KLHL32

9.47e-051437447a7a9829ba63468c9745904d9e993590051207ab
ToppCellVE-CD8-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster

TBC1D30 PZP DTHD1 OMG

1.08e-04148744f49f579650b57cc4c6c7a7fa726447740d3dc695
ToppCellRV-17._Lymphocyte|RV / Chamber and Cluster_Paper

DOCK2 PZP DTHD1 PYHIN1

1.23e-04153744e1ea621184014415870e00d511386b8cc3e0833b
ToppCellRV-17._Lymphocyte|World / Chamber and Cluster_Paper

DOCK2 PZP DTHD1 PYHIN1

1.29e-04155744189276a3b400b2202e6681e23732e6452bfe704e
ToppCellLeuk-UTI-Lymphocyte-T_NK-gdT|Leuk-UTI / Disease, Lineage and Cell Type

PZP DTHD1 MYBL1 PYHIN1

1.39e-04158744c4b0af25608cee3d0d2b0193f5ff45d9dc87078b
ToppCellfacs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

AADAC MROH2A KLHL32 BDNF

1.46e-04160744f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CLTC NPC2 MYO16

1.53e-0416274406f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3
ToppCellPND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

ANK3 CLTC NPC2 MYO16

1.53e-04162744d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918
ToppCelldroplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DOCK2 ATP7A ADGRE1 KLHL32

1.57e-041637448dc0128eeede933537e3bcc5d6ec0322711552f3
DiseaseAlcohol Related Neurodevelopmental Disorder

ANK3 NOS1

5.52e-055702C0814154
DiseasePartial Fetal Alcohol Syndrome

ANK3 NOS1

5.52e-055702C3661483
DiseaseAlcohol Related Birth Defect

ANK3 NOS1

8.27e-056702C3146244
DiseaseCOVID-19, obesity

KLHL32 BDNF

1.16e-047702EFO_0001073, MONDO_0100096
Diseasesleep apnea

PPP1R3A MACF1 BDNF

1.19e-0440703EFO_0003877
Diseaseacoustic neuroma (is_marker_for)

NF2 BDNF

1.98e-049702DOID:12689 (is_marker_for)
DiseaseFetal Alcohol Spectrum Disorders

ANK3 NOS1

4.25e-0413702C2985290
Diseasediabetic neuropathy (implicated_via_orthology)

TRPA1 BDNF

4.96e-0414702DOID:9743 (implicated_via_orthology)
DiseasePetit mal status

ANK3 NOS1 BDNF

5.49e-0467703C0270823
DiseaseGrand Mal Status Epilepticus

ANK3 NOS1 BDNF

5.49e-0467703C0311335
DiseaseStatus Epilepticus, Subclinical

ANK3 NOS1 BDNF

5.49e-0467703C0751522
DiseaseSimple Partial Status Epilepticus

ANK3 NOS1 BDNF

5.49e-0467703C0751524
DiseaseNon-Convulsive Status Epilepticus

ANK3 NOS1 BDNF

5.49e-0467703C0751523
DiseaseComplex Partial Status Epilepticus

ANK3 NOS1 BDNF

5.49e-0467703C0393734
DiseaseStatus Epilepticus

ANK3 NOS1 BDNF

5.74e-0468703C0038220
DiseaseFetal Alcohol Syndrome

ANK3 NOS1

7.37e-0417702C0015923
Diseasecolorectal cancer, hormone replacement therapy

PPP1R3A MORC3 MYO16

1.21e-0388703EFO_0003961, MONDO_0005575
DiseaseVisual seizure

ATP7A NOS1 BDNF

1.80e-03101703C0270824
DiseaseEpileptic drop attack

ATP7A NOS1 BDNF

1.80e-03101703C0270846
DiseaseGeneralized seizures

ATP7A NOS1 BDNF

1.80e-03101703C0234533
DiseaseClonic Seizures

ATP7A NOS1 BDNF

1.80e-03101703C0234535
DiseaseVertiginous seizure

ATP7A NOS1 BDNF

1.80e-03101703C0422855
DiseaseGustatory seizure

ATP7A NOS1 BDNF

1.80e-03101703C0422854
DiseaseSeizures, Somatosensory

ATP7A NOS1 BDNF

1.80e-03101703C0422850
DiseaseOlfactory seizure

ATP7A NOS1 BDNF

1.80e-03101703C0422853
DiseaseSeizures, Auditory

ATP7A NOS1 BDNF

1.80e-03101703C0422852
DiseaseGeneralized Absence Seizures

ATP7A NOS1 BDNF

1.80e-03101703C4505436
DiseaseConvulsive Seizures

ATP7A NOS1 BDNF

1.80e-03101703C0751494
DiseaseSeizures, Sensory

ATP7A NOS1 BDNF

1.80e-03101703C0751496
DiseaseJacksonian Seizure

ATP7A NOS1 BDNF

1.80e-03101703C0022333
DiseaseNon-epileptic convulsion

ATP7A NOS1 BDNF

1.80e-03101703C0751056
DiseaseAtonic Absence Seizures

ATP7A NOS1 BDNF

1.80e-03101703C0751123
DiseaseComplex partial seizures

ATP7A NOS1 BDNF

1.80e-03101703C0149958
DiseaseSingle Seizure

ATP7A NOS1 BDNF

1.80e-03101703C0751110
DiseaseEpileptic Seizures

ATP7A NOS1 BDNF

1.80e-03101703C4317109
DiseaseNonepileptic Seizures

ATP7A NOS1 BDNF

1.80e-03101703C3495874
DiseaseSeizures

ATP7A MACF1 NOS1 BDNF

1.82e-03218704C0036572
DiseaseTonic Seizures

ATP7A NOS1 BDNF

1.86e-03102703C0270844
DiseaseAbsence Seizures

ATP7A NOS1 BDNF

1.86e-03102703C4316903
DiseaseConvulsions

ATP7A NOS1 BDNF

1.86e-03102703C4048158
DiseaseSeizures, Focal

ATP7A NOS1 BDNF

1.96e-03104703C0751495
DiseaseMyoclonic Seizures

ATP7A NOS1 BDNF

1.96e-03104703C4317123
DiseaseTonic - clonic seizures

ATP7A NOS1 BDNF

1.96e-03104703C0494475

Protein segments in the cluster

PeptideGeneStartEntry
VLEKVPVSKGQLKQY

BDNF

166

P23560
YQPIIKEILKNFPKE

CARNMT1

181

Q8N4J0
PDVKIKLKIQSLIYP

AADAC

206

P22760
TPLQKAQVVELVKKY

ATP8B4

791

Q8TF62
ETSLQVYKPLPKIQE

ARMCX5

191

Q6P1M9
KNATIIYDPKLQTPK

ATP7A

46

Q04656
TQEIINKYLPPKIEN

RAD54B

531

Q9Y620
PKFEVKVQVPKIISI

PZP

226

P20742
YVPVPKQTIKKTKRN

RBM34

71

P42696
IKYGKPIPKISLENV

PPM1K

81

Q8N3J5
SRKIYKFIQKVPIPC

LTA4H

186

P09960
NKLPVKSEYPSIKLV

NPC2

111

P61916
LIKYQPKPKQIRISS

LTV1

366

Q96GA3
VKKLPVLETNLKYPV

MYO16

1516

Q9Y6X6
VLKEPKVVLYKNLPI

KMT5B

476

Q4FZB7
KVKKNTEYPLNLPVE

MORC3

386

Q14149
NKITNVSAVIKPYPK

PI4KAP1

206

Q8N8J0
KVPLNQYQVREVIKK

LRRC74A

456

Q0VAA2
VVQYLPTLQEKKVIP

NUP214

216

P35658
LPPKAKVLIKITYIT

PARP4

721

Q9UKK3
VNAVYLLPVPKQKLV

HELZ

531

P42694
YIVPDKQIFRKPQQK

POLA1

801

P09884
ILQKAKLSVYVQPPL

BBS9

451

Q3SYG4
KPPSAEYKVVKAQIQ

MACF1

5371

Q9UPN3
KLLYILNPPETQVEK

RBBP6

1586

Q7Z6E9
QVKKQILDEKIYCPP

NF2

121

P35240
PDKPKKYVQDILQEQ

NOS1

1321

P29475
KIVLVPPYQKDGSKV

PPP1R3A

191

Q16821
VNVYVNPKKLTVIKA

INTU

161

Q9ULD6
PELLKQKLQSYKISP

PRIM2

391

P49643
LTFQIYVKKTPQKKP

C2CD3

641

Q4AC94
YVKKTPQKKPEVIGS

C2CD3

646

Q4AC94
YKKPEKTKLQIIPGQ

DOCK11

571

Q5JSL3
EFYTCIPPVKLQKQK

DOCK2

821

Q92608
KKLENYKIPVPINAE

BTAF1

1251

O14981
KKIFPNQKPTVLELI

DMRT3

256

Q9NQL9
IISNKPYKIPNTELI

DIS3L

971

Q8TF46
KIPKVELQISIYGVK

GULP1

66

Q9UBP9
IYGVKILEPKTKEVQ

GULP1

76

Q9UBP9
KPQFPEKVYQIKLPE

FAT3

1251

Q8TDW7
IIPSKKTKQKEVYPA

PYHIN1

101

Q6K0P9
IPVKKIQESKLPVYQ

ANK3

2746

Q12955
TIVVYKVPKGKIVPN

DTHD1

616

Q6ZMT9
SFIAIPPKKIQDKII

CSN3

116

P07498
PFKVVEKKTKPYIQV

HSPA5

116

P11021
KDKPLGVQQKYLVVT

POLI

76

Q9UNA4
QEKKYGPLKIVSQPL

MYBL1

566

P10243
NKILIVTQTPPYVKK

LARP1B

446

Q659C4
SKKQLVKPEQLPIYT

APOOL

31

Q6UXV4
YNPEVKLGVIKSLKP

MROH2A

271

A6NES4
PLKPYISNPKKIEVQ

NRK

771

Q7Z2Y5
QLLVNPKKIIKKPEY

ORC2

41

Q13416
PALEKKPQVAYKTEI

PLEKHA2

136

Q9HB19
IIFVPVPQLKSFQKI

RPS7

61

P62081
YKDEKEQLIIPQVPL

USP39

401

Q53GS9
LKILQKTQPTYPSVK

NKRF

406

O15226
KQQVPYKEDKPQVPL

SIN3B

141

O75182
NKITNVSAVIKPYPK

PI4KAP2

206

A4QPH2
PSQKEYLEINKIPLV

OR6J1

261

Q8NGC5
TQPKVTKIPKQYRTK

OMG

296

P23515
LKKIKTETYPQGQPV

SRBD1

181

Q8N5C6
PIIYTLENIQPKQKF

ADGRE1

531

Q14246
KKEKLIKNTYLPQVP

ANKUB1

436

A6NFN9
VNYFSKVKQLPLVKP

CLTC

1436

Q00610
KVKQLPLVKPYLRSV

CLTC

1441

Q00610
QYPEKVIPKFISLLQ

TGDS

201

O95455
YQLPKKEKRVTVQLP

XIRP2

2596

A4UGR9
RKVDQKSTIVYPNKP

TRPA1

996

O75762
LAPELQKYQKQIKEP

TBC1D30

581

Q9Y2I9
KKIPYVDTQGQLIKP

UAP1

356

Q16222
LVPTVKEKYPVLKDV

ZZEF1

1546

O43149
AVKKEEKCVPPYVQI

TASOR2

1901

Q5VWN6
VKPPQLIDYLQQKKT

TARBP1

1521

Q13395
KLKIPKNPELVPQNY

VWA8

66

A3KMH1
KLPPIYKVREKQAVN

TEX36

51

Q5VZQ5
QVLPTVERYCPKKNK

KLHL32

411

Q96NJ5
LEIKVEYVPKQEPPK

MYBPC2

526

Q14324